Tirzepatide Product Description
Tirzepatide is a synthetic, long-acting research peptide that functions as a dual receptor agonist targeting GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism makes it highly relevant in laboratory studies focused on glucose metabolism, insulin sensitivity, and appetite regulation.
Engineered for prolonged activity, Tirzepatide is widely studied for its role in metabolic research, particularly in areas involving weight regulation, glycemic control, and energy balance. Its combined incretin receptor activity offers enhanced effects compared to single-pathway peptides, making it a valuable compound in advanced endocrinology and obesity-related studies.
Peptide Information
| Property | Value |
|---|---|
| Peptide Type | Dual Agonist (GLP-1, GIP) |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | ~4813 g/mol |
| CAS Number | 2023788-19-2 |
| PubChem CID | 16220172 |
| Synonyms | LY3298176, Dual Incretin Agonist, GLP-1/GIP Agonist |
Lyophilized Peptides:
This peptide is supplied in lyophilized (freeze-dried) form to maintain stability, purity, and structural integrity over time. This process helps extend shelf life and ensures consistency for research purposes without the use of fillers.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information provided is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not intended for human consumption, medical, veterinary, or cosmetic use.
Be the first to review “Tirzepatide”
Related products
Vials
Vials
Vials
Vials
Vials
Vials
Reviews
There are no reviews yet.